Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 1 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Cardiovascular mortality · patients with stable angina pectoris

Ranolazine (monotherapy) showed no clear difference in cardiovascular mortality compared with placebo (low certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 1.03 [0.56, 1.88]
1 study · 2604 participants
Low

Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris

The review found no eligible studies for this question.

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found